Applied Therapeutics Inc (NASDAQ:APLT) has a beta value of 2.01 and has seen 1.73 million shares traded in the last trading session. The company, currently valued at $1.16B, closed the last trade at $9.62 per share which meant it gained $0.35 on the day or 3.83% during that session. The APLT stock price is -10.4% off its 52-week high price of $10.62 and 81.39% above the 52-week low of $1.79. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.81 million shares traded. The 3-month trading volume is 2.66 million shares.
The consensus among analysts is that Applied Therapeutics Inc (APLT) is Buy stock at the moment, with a recommendation rating of 1.17. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.17.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Sporting 3.83% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the APLT stock price touched $9.62 or saw a rise of 2.43%. Year-to-date, Applied Therapeutics Inc shares have moved 187.31%, while the 5-day performance has seen it change 10.76%. Over the past 30 days, the shares of Applied Therapeutics Inc (NASDAQ:APLT) have changed 7.90%. Short interest in the company has seen 12.14 million shares shorted with days to cover at 7.18.
Applied Therapeutics Inc (APLT) estimates and forecasts
Figures show that Applied Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 135.91% over the past 6 months, with this year growth rate of 9.15%, compared to 18.00% for the industry. Revenue growth from the last financial year stood is estimated to be -93.31%.
3 analysts offering their estimates for the company have set an average revenue estimate of 183.33k for the current quarter. 2 have an estimated revenue figure of 19.15M for the next ending quarter. Year-ago sales stood 9.99M and 190k respectively for this quarter and the next, and analysts expect sales will shrink by -98.17% for the current quarter and -93.31% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.72% over the past 5 years.
APLT Dividends
Applied Therapeutics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
Insiders own 5.24% of the company shares, while shares held by institutions stand at 101.87% with a share float percentage of 107.50%. Investors are also buoyed by the number of investors in a company, with Applied Therapeutics Inc having a total of 165.0 institutions that hold shares in the company. The top two institutional holders are FRANKLIN RESOURCES INC with over 10.21 million shares worth more than $47.69 million. As of 2024-06-30, FRANKLIN RESOURCES INC held 8.1496% of shares outstanding.
The other major institutional holder is VR ADVISER, LLC, with the holding of over 9.54 million shares as of 2024-06-30. The firm’s total holdings are worth over $44.57 million and represent 7.6149% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Franklin Strategic Series-Franklin Biotechnology Discove and Vanguard Total Stock Market Index Fund . As of Jul 31, 2024 , the former fund manager holds about 2.97% shares in the company for having 3.45 shares of worth $33.21 million while later fund manager owns 3.15 shares of worth $30.36 million as of Jun 30, 2024 , which makes it owner of about 2.71% of company’s outstanding stock.
